Healthtech, encompassing everything from digital therapeutics to artificial intelligence (AI)-driven diagnostics, is reshaping healthcare and becoming a crucial element of healthcare delivery by enhancing accessibility, convenience, and personalization of services. As healthcare costs continue to rise, driven by factors such as aging populations, prevalence of chronic diseases, and increasing costs of treatments, healthtech offers ways to make healthcare more affordable and sustainable.
Healthtech provides an opportunity to make healthcare more patient-centric - a model believed to be a promising way to decrease costs while at the same time improving health-related quality of life. By focusing on individual patient needs through personalized care plans, healthtech empowers patients to take more active role in managing their health, ultimately driving down healthcare costs.
Healthtech provides an opportunity to make healthcare more patient-centric - a model believed to be a promising way to decrease costs while at the same time improving health-related quality of life. By focusing on individual patient needs through personalized care plans, healthtech empowers patients to take more active role in managing their health, ultimately driving down healthcare costs.
Key Findings of the report include:
- South Korea’s drug development is growing, focusing on early R&D and CGTs.
- South Korea is advancing therapies like ADCs, mRNA, and CAR-T.
- The rise in drug approvals in recent years highlights South Korea’s strong regulatory support.
- South Korea’s pharma deals have slowed in recent years, but strategic alliances remain key.
- Phase I clinical trials have become the focus in South Korea, representing the largest category.
Scope
- The analyst’s Healthtech report provides in-house analyst expertise on the impact of the five broad innovation categories (personalized and precision medicine, virtual care (telemedicine), artificial intelligence, robotics and virtual/augmented reality) and highlights big players in key healthcare technology categories.
- Components of the report include:
- Key Players - identify the big players in key healthcare innovation categories that may be disrupted over the next two years.
- Trends in Healthtech - identify key trends expected to occur in the global healthcare sector over the next two years.
- Industry Analysis - identify the impact of innovations across major markets.
- Value Chain - identify the five primary ways in which technology is changing the delivery of healthcare: prevention, diagnosis, treatment, monitoring, and recording.
Reasons to Buy
- Develop and design your corporate strategies through an in-house expert analysis of the five broad innovation categories expected to impact the healthcare industry.
- Develop business strategies by understanding the primary ways in which technology is changing the delivery of healthcare.
- Stay up to date on the industry’s major players in healthtech and where they sit in the value chain.
- Identify emerging industry trends in in the global healthcare sector to gain a competitive advantage.
Table of Contents
- Executive Summary
- Players
- Innovation Briefing
- The impact of healthtech innovations on the value chain
- Prevention
- Diagnosis
- Treatment
- Monitoring
- Patient engagement
- Trends
- Healthcare trends
- Technology trends
- Macroeconomic trends
- Regulatory trends
- Industry Analysis
- Use Cases of Healthtech
- Versius surgical system: advancing precision and innovation in robotic surgery
- In clinical trials, the role of telemedicine surged during COVID-19 and still remains prominent
- Empowered patients are contributing towards increased use of healthtech
- AI use in clinical practice - physicians’ perspective
- Timeline
- Signals
- M&A trends
- Venture financing trends
- Strategic partnership trends
- Hiring trends
- Social media trends
- Value Chain
- Companies
- Public companies
- Private companies
- Sector Scorecards
- Pharmaceutical sector scorecards
- Who’s who
- Thematic screen for drug development
- Thematic screen for clinical trials
- Thematic screen for drug manufacturing
- Valuation screen
- Risk screen
- Abbreviations
- Further Reading
- The analyst reports
- Thematic Research Methodology
- About the Analyst
- Contact the Publisher
Table 1: Healthcare trends
Table 2: Technology trends
Table 3: Macroeconomic trends
Table 4: Regulatory trends
Table 5: The key M&A transactions associated with the artificial intelligence theme since January 2024
Table 6: The key M&A transactions associated with the personalized and precision medicine theme since January 2024
Table 7: The key M&A transactions associated with the virtual care theme since January 2024
Table 8: The key M&A transactions associated with the VR/AR theme since January 2024
Table 9: The key M&A transactions associated with the robotics theme since January 2024
Table 10: Key venture financing deals associated with the artificial intelligence theme
Table 11: The key venture financing deals associated with the personalized and precision medicine theme since January 2024
Table 12: The key venture financing deals associated with the virtual care theme since January 2024
Table 13: The key venture financing deals associated with the VR/AR theme since January 2024
Table 14: The key venture financing deals associated with the robotics theme since January 2024
Table 15: The key strategic partnerships associated with the artificial intelligence theme since January 2024
Table 16: The key strategic partnerships associated with the personalized and precision medicine theme since January 2024
Table 17: The Key strategic partnerships associated with the virtual care theme since January 2024
Table 18: The key strategic partnership associated with the robotics theme since January 2024
Table 19: Public companies
Table 20: Private companies
Table 21: Abbreviations
Table 22: the analyst reports
List of Figures
Figure 1: Trends in global health and healthcare
Figure 2: Players in the healthtech theme
Figure 3: Integration of healthtech enhances the healthcare value chain
Figure 4: Current health expenditure in current PPP per capita in $ (Canada, Mexico, US, France, Germany, Italy, Spain, UK, Australia, Japan, and South Korea)
Figure 5: The growth of the AI healthcare market between 2024-28 (Canada, Mexico, US, France, Germany, Italy, Spain, UK, Australia, Japan, and South Korea combined)
Figure 6: Patients’ view on AI use in healthcare (Patients’ agreement level that using AI in healthcare could improve patient care)
Figure 7: Telemedicine use in clinical trials
Figure 8: HCPs’ views on virtual care role on patient empowerment
Figure 9: Trends influencing patient empowerment
Figure 10: Physician comfort level with using AI
Figure 11: The healthtech story
Figure 12: Healthtech M&A deals
Figure 13: Healthtech venture financing trends
Figure 14: Healthtech strategic partnership trends
Figure 15: Healthtech hiring trends
Figure 16: Healthtech social media trends
Figure 17: The personalized and precision medicine value chain
Figure 18: The telemedicine value chain
Figure 19: The artificial intelligence value chain
Figure 20: Robotics value chain
Figure 21: The virtual reality value chain
Figure 22: The augmented reality value chain
Figure 23: Who does what in the pharmaceutical sector?
Figure 24: Our thematic screen ranks companies based on overall leadership in the 10 themes that matter most to their industry, generating a leading indicator of future performance.
Figure 25: Our thematic screen ranks companies based on overall leadership in the 10 themes that matter most to their industry, generating a leading indicator of future performance.
Figure 26: Our thematic screen ranks companies based on overall leadership in the 10 themes that matter most to their industry, generating a leading indicator of future performance.
Figure 27: Our valuation screen ranks our universe of companies within a sector based on selected valuation metrics
Figure 28: Our risk screen ranks companies within a particular sector based on overall investment risk
